305 related articles for article (PubMed ID: 26630272)
1. Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells.
Huang H; Chen X; Li D; He Y; Li Y; Du Z; Zhang K; DiPaola R; Goodin S; Zheng X
PLoS One; 2015; 10(12):e0144293. PubMed ID: 26630272
[TBL] [Abstract][Full Text] [Related]
2. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling.
Lee ST; Wong PF; He H; Hooper JD; Mustafa MR
PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404
[TBL] [Abstract][Full Text] [Related]
3. Alpha-tomatine synergises with paclitaxel to enhance apoptosis of androgen-independent human prostate cancer PC-3 cells in vitro and in vivo.
Lee ST; Wong PF; Hooper JD; Mustafa MR
Phytomedicine; 2013 Nov; 20(14):1297-305. PubMed ID: 23920276
[TBL] [Abstract][Full Text] [Related]
4. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
5. Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells.
Lee ST; Wong PF; Cheah SC; Mustafa MR
PLoS One; 2011 Apr; 6(4):e18915. PubMed ID: 21541327
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo.
Wang ZS; Huang HR; Zhang LY; Kim S; He Y; Li DL; Farischon C; Zhang K; Zheng X; Du ZY; Goodin S
Biol Pharm Bull; 2017; 40(8):1247-1254. PubMed ID: 28769006
[TBL] [Abstract][Full Text] [Related]
7. Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro.
Chen MB; Wu XY; Tao GQ; Liu CY; Chen J; Wang LQ; Lu PH
Int J Cancer; 2012 Dec; 131(11):2487-98. PubMed ID: 22438101
[TBL] [Abstract][Full Text] [Related]
8. Effects of pyridine analogs of curcumin on growth, apoptosis and NF-κB activity in prostate cancer PC-3 cells.
Wei X; Zhou D; Wang H; Ding N; Cui XX; Wang H; Verano M; Zhang K; Conney AH; Zheng X; DU ZY
Anticancer Res; 2013 Apr; 33(4):1343-50. PubMed ID: 23564771
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
[TBL] [Abstract][Full Text] [Related]
10. Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer.
Yang J; Ning J; Peng L; He D
Int J Clin Exp Pathol; 2015; 8(8):9272-8. PubMed ID: 26464676
[TBL] [Abstract][Full Text] [Related]
11. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
12. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
[TBL] [Abstract][Full Text] [Related]
13. Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.
Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Valeriote FA; Gautam SC
J Exp Ther Oncol; 2016 Nov; 11(4):251-260. PubMed ID: 27849335
[TBL] [Abstract][Full Text] [Related]
14. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
16. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
He Y; Huang H; Farischon C; Li D; Du Z; Zhang K; Zheng X; Goodin S
Oncol Rep; 2017 Feb; 37(2):953-960. PubMed ID: 28075470
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.
Andrzejewski T; Deeb D; Gao X; Danyluk A; Arbab AS; Dulchavsky SA; Gautam SC
Oncol Res; 2008; 17(6):257-67. PubMed ID: 19192720
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
20. α-Tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells.
Huang H; Chen S; Van Doren J; Li D; Farichon C; He Y; Zhang Q; Zhang K; Conney AH; Goodin S; Du Z; Zheng X
Mol Med Rep; 2015 Jun; 11(6):4573-8. PubMed ID: 25625536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
